Veracyte, Inc.
Veracyte, a leading genomic diagnostics company, improves patient care by providing trustworthy and actionable answers to challenging clinical questions. The company's tests, the Afirma® Genomic Sequencing Classifier (GSC) and the Afirma Xpression Atlas, provide physicians with a comprehensive solution for a complex landscape in thyroid nodule diagnosis. Learn more at www.Afirma.com.